Stay updated with breaking news from Donna Ryan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
<p>New findings show that the medication known as Wegovy® (semaglutide) can reduce existing heart disease in patients with obesity by 20%, according to a study co-authored by past presidents of The Obesity Society and published in <em>The</em> <em>New England Journal of Medicine</em>.</p>
Who doesn't dream of traveling during their retirement years? While travel is considered an important retirement goal for many, retirees often need to err on the side of financial practicality. In a...
At 12 months, there was an average weight loss of 16.2%, with results sustained up to 24 months
In this limited series, we speak with experts to understand the new frontier of anti-obesity drugs, as well as concerns and questions that still remain.
I could only shake my head when I read Dr. Donna Ryan’s letter regarding U.S. Sen. Bill Cassidy's bill that would allow Medicare funds to be used for anti-obesity drugs.